Turkish Journal of Hematology最新文献

筛选
英文 中文
The Advancing Landscape of Paroxysmal Nocturnal Hemoglobinuria Treatment 阵发性夜间血红蛋白尿治疗进展。
IF 1.5 4区 医学
Turkish Journal of Hematology Pub Date : 2025-05-22 Epub Date: 2025-04-21 DOI: 10.4274/tjh.galenos.2025.2025.0054
Cameron Perry, Xinyu Von Buttlar, Swapna Thota
{"title":"The Advancing Landscape of Paroxysmal Nocturnal Hemoglobinuria Treatment","authors":"Cameron Perry, Xinyu Von Buttlar, Swapna Thota","doi":"10.4274/tjh.galenos.2025.2025.0054","DOIUrl":"10.4274/tjh.galenos.2025.2025.0054","url":null,"abstract":"<p><p>Paroxysmal nocturnal hemoglobinuria (PNH) is a rare chronic bone marrow failure condition characterized by complement-mediated hemolytic anemia and thrombosis. While its initial clinical description occurred in 1882, somatic mutations in <i>PIGA</i> were discovered in the 1990s. With an improved understanding of PNH biology, a focused effort on complement inhibitors led to the discovery of eculizumab, a C5 inhibitor initially approved by the US Food and Drug Administration in 2007. Terminal complement pathway inhibition reduced intravascular hemolysis, anemia, and thrombosis. Further advancements in drug development for PNH have included improved pharmacokinetics with ravulizumab in 2018 and the introduction of proximal complement inhibitors such as pegcetacoplan (2021), iptacopan (2023), danicopan (2024), and crovalimab (2024) to enhance patient outcomes. With these new proximal and distal complement inhibitors in the treatment landscape, it is timely for clinicians to review the evolving landscape of PNH treatments and patient selection.</p>","PeriodicalId":23362,"journal":{"name":"Turkish Journal of Hematology","volume":" ","pages":"74-81"},"PeriodicalIF":1.5,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12099479/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144048645","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extranodal NK/T-Cell Lymphoma, Nasal Type 结外NK/ t细胞淋巴瘤,鼻型。
IF 1.5 4区 医学
Turkish Journal of Hematology Pub Date : 2025-05-22 Epub Date: 2025-03-27 DOI: 10.4274/tjh.galenos.2025.2025.0079
Ankur Jain
{"title":"Extranodal NK/T-Cell Lymphoma, Nasal Type","authors":"Ankur Jain","doi":"10.4274/tjh.galenos.2025.2025.0079","DOIUrl":"10.4274/tjh.galenos.2025.2025.0079","url":null,"abstract":"","PeriodicalId":23362,"journal":{"name":"Turkish Journal of Hematology","volume":" ","pages":"144-145"},"PeriodicalIF":1.5,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12099472/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143721326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optical Genome Mapping as a New Approach to Detecting Cytogenetic Abnormalities: Why Is It Difficult in Multiple Myeloma? 光学基因组定位-一种检测细胞遗传学异常的新方法:为什么在多发性骨髓瘤中很难?
IF 1.5 4区 医学
Turkish Journal of Hematology Pub Date : 2025-05-22 Epub Date: 2025-04-15 DOI: 10.4274/tjh.galenos.2025.2025.0052
Ayşe Gül Bayrak Tokaç, Mehmet Burak Mutlu, Simge Erdem, Aynur Aday
{"title":"Optical Genome Mapping as a New Approach to Detecting Cytogenetic Abnormalities: Why Is It Difficult in Multiple Myeloma?","authors":"Ayşe Gül Bayrak Tokaç, Mehmet Burak Mutlu, Simge Erdem, Aynur Aday","doi":"10.4274/tjh.galenos.2025.2025.0052","DOIUrl":"10.4274/tjh.galenos.2025.2025.0052","url":null,"abstract":"","PeriodicalId":23362,"journal":{"name":"Turkish Journal of Hematology","volume":" ","pages":"165-166"},"PeriodicalIF":1.5,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12099464/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144047310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy, Safety, and Tolerability of Ferric Carboxymaltose and Iron Sucrose in Iron-Deficiency Anemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 羧基麦芽糖铁和蔗糖铁治疗缺铁性贫血的疗效、安全性和耐受性:随机对照试验的系统评价和荟萃分析。
IF 1.5 4区 医学
Turkish Journal of Hematology Pub Date : 2025-05-22 Epub Date: 2025-03-17 DOI: 10.4274/tjh.galenos.2025.2025.0034
Lokman Hekim Tanrıverdi, Ahmet Sarıcı
{"title":"Efficacy, Safety, and Tolerability of Ferric Carboxymaltose and Iron Sucrose in Iron-Deficiency Anemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","authors":"Lokman Hekim Tanrıverdi, Ahmet Sarıcı","doi":"10.4274/tjh.galenos.2025.2025.0034","DOIUrl":"10.4274/tjh.galenos.2025.2025.0034","url":null,"abstract":"<p><strong>Objective: </strong>This study comprehensively compares the efficacy, safety, and tolerability of two commonly used intravenous iron preparations, ferric carboxymaltose (FCM) and iron sucrose (IS), in adult patients with iron-deficiency anemia (IDA).</p><p><strong>Materials and methods: </strong>A systematic literature search was conducted across the PubMed, Ovid MEDLINE, Web of Science, and Cochrane Library databases up to January 1, 2024, to identify randomized controlled trials directly comparing FCM and IS treatments in adult patients with IDA. The primary outcome of interest was change in hemoglobin (Hb) levels during follow-up. Meta-analyses were conducted with inverse variance random effects models.</p><p><strong>Results: </strong>Fourteen trials were included in the study, with a total of 4757 patients. FCM resulted in a non-significant increase in Hb levels (mean difference [MD]: 0.45 g/dL, 95% confidence interval [CI]: 0.08 to 0.83, p=0.02) and ferritin levels (MD: 37.32 ng/mL, 95% CI: 18.98 to 55.65, p<0.01) compared to IS. FCM was associated with a higher risk of hypersensitivity reactions compared to IS (relative risk [RR]: 2.97, 95% CI: 1.35 to 6.52, p<0.01) but showed no significant difference in severe adverse events (RR: 1.03, 95% CI: 0.88 to 1.21, p=0.70) and had a non-significant increased risk of hypophosphatemia (RR: 2.84, 95% CI: 0.89 to 9.06, p=0.08).</p><p><strong>Conclusion: </strong>Ten studies showed some concerns of risk of bias (RoB) and four studies had a high RoB for the change in Hb levels during follow-up. The lack of standardized definitions for hypersensitivity reactions and variability in dosing protocols and follow-up durations across studies may affect the generalizability of our safety findings.</p>","PeriodicalId":23362,"journal":{"name":"Turkish Journal of Hematology","volume":" ","pages":"119-135"},"PeriodicalIF":1.5,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12099480/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143650809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Rare Case of Non-Hodgkin Lymphoma Presenting as a Penile Mass 一例罕见的非霍奇金淋巴瘤,表现为起源于海绵体的肿块。
IF 1.5 4区 医学
Turkish Journal of Hematology Pub Date : 2025-05-22 Epub Date: 2025-03-10 DOI: 10.4274/tjh.galenos.2025.2024.0374
Ahmet Halil Sevinç, İlker Teke, Özge Hürdoğan, Ali Altay, Zeynep Cantürk, Murat Dursun, Ateş Kadıoğlu
{"title":"A Rare Case of Non-Hodgkin Lymphoma Presenting as a Penile Mass","authors":"Ahmet Halil Sevinç, İlker Teke, Özge Hürdoğan, Ali Altay, Zeynep Cantürk, Murat Dursun, Ateş Kadıoğlu","doi":"10.4274/tjh.galenos.2025.2024.0374","DOIUrl":"10.4274/tjh.galenos.2025.2024.0374","url":null,"abstract":"","PeriodicalId":23362,"journal":{"name":"Turkish Journal of Hematology","volume":" ","pages":"153-155"},"PeriodicalIF":1.5,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12099473/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143587201","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute Myeloid Leukemia with NUP98::LNP1 Fusion Mimicking Chronic Myeloid Leukemia 急性髓性白血病与 NUP98::LNP1 融合模拟慢性髓性白血病
IF 1.5 4区 医学
Turkish Journal of Hematology Pub Date : 2025-05-22 Epub Date: 2025-03-17 DOI: 10.4274/tjh.galenos.2025.2024.0391
Haiyang Wang, Yu Peng, Zailin Yang
{"title":"Acute Myeloid Leukemia with <i>NUP98::LNP1</i> Fusion Mimicking Chronic Myeloid Leukemia","authors":"Haiyang Wang, Yu Peng, Zailin Yang","doi":"10.4274/tjh.galenos.2025.2024.0391","DOIUrl":"10.4274/tjh.galenos.2025.2024.0391","url":null,"abstract":"","PeriodicalId":23362,"journal":{"name":"Turkish Journal of Hematology","volume":" ","pages":"142-143"},"PeriodicalIF":1.5,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12099463/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143650695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What Happened Suddenly - Acute Abdomen? A Difficult Case of ATRA-Related Pneumatosis Cystoides Intestinalis 怎么回事:突然发作还是急腹症?ATRA相关性肠囊性肺肿难治性病例。
IF 1.5 4区 医学
Turkish Journal of Hematology Pub Date : 2025-05-22 Epub Date: 2025-03-19 DOI: 10.4274/tjh.galenos.2025.2025.0020
Merve Ecem Erdoğan Yön, Ahmet Ceylan, Emel İşleyen Kaya, Esin Ölçücüoğlu, Funda Ceran, Simten Dağdaş, Gülsüm Özet
{"title":"What Happened Suddenly - Acute Abdomen? A Difficult Case of ATRA-Related Pneumatosis Cystoides Intestinalis","authors":"Merve Ecem Erdoğan Yön, Ahmet Ceylan, Emel İşleyen Kaya, Esin Ölçücüoğlu, Funda Ceran, Simten Dağdaş, Gülsüm Özet","doi":"10.4274/tjh.galenos.2025.2025.0020","DOIUrl":"10.4274/tjh.galenos.2025.2025.0020","url":null,"abstract":"","PeriodicalId":23362,"journal":{"name":"Turkish Journal of Hematology","volume":" ","pages":"150-152"},"PeriodicalIF":1.5,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12099487/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143658736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Successful Treatment of Childhood Hodgkin Lymphoma and Secondary Myelofibrosis Resistant to Intensive Therapy, Including Allogeneic Transplantation 成功治疗对强化治疗(包括同种异体移植)耐药的儿童霍奇金淋巴瘤和继发性骨髓纤维化。
IF 1.5 4区 医学
Turkish Journal of Hematology Pub Date : 2025-05-22 Epub Date: 2025-04-07 DOI: 10.4274/tjh.galenos.2025.2025.0044
Deniz Koçak Göl, Veysel Gök, Alper Özcan, Ebru Yılmaz, Ekrem Ünal, Ümmühan Abdülrezzak, Özlem Canöz, Musa Karakükcü
{"title":"Successful Treatment of Childhood Hodgkin Lymphoma and Secondary Myelofibrosis Resistant to Intensive Therapy, Including Allogeneic Transplantation","authors":"Deniz Koçak Göl, Veysel Gök, Alper Özcan, Ebru Yılmaz, Ekrem Ünal, Ümmühan Abdülrezzak, Özlem Canöz, Musa Karakükcü","doi":"10.4274/tjh.galenos.2025.2025.0044","DOIUrl":"10.4274/tjh.galenos.2025.2025.0044","url":null,"abstract":"","PeriodicalId":23362,"journal":{"name":"Turkish Journal of Hematology","volume":" ","pages":"158-160"},"PeriodicalIF":1.5,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12099488/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143796427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
hsa_circRNA_092488 Exacerbates the Progression of Deep Vein Thrombosis Through the NLRP3/NF-κB Signaling Pathway Hsa_circRNA_092488通过NLRP3/NFkB信号通路加剧深静脉血栓形成的进展
IF 1.5 4区 医学
Turkish Journal of Hematology Pub Date : 2025-05-22 Epub Date: 2025-03-06 DOI: 10.4274/tjh.galenos.2025.2024.0160
Jian Wang, Binghui Du
{"title":"hsa_circRNA_092488 Exacerbates the Progression of Deep Vein Thrombosis Through the NLRP3/NF-κB Signaling Pathway","authors":"Jian Wang, Binghui Du","doi":"10.4274/tjh.galenos.2025.2024.0160","DOIUrl":"10.4274/tjh.galenos.2025.2024.0160","url":null,"abstract":"<p><strong>Objective: </strong>Deep vein thrombosis (DVT) is a vascular disorder with an incidence rate of about 0.1%. Endothelial progenitor cells (EPCs) are precursor cells of endothelial cells and contribute to vascular repair and regeneration. Circular RNA (circRNA) has become a new focus of research as circRNAs are involved in various biological processes including the progression of DVT. This study explored the upregulation of hsa_circRNA_092488 in DVT patients.</p><p><strong>Materials and methods: </strong>The expression of hsa_circRNA_092488 was evaluated in venous blood samples obtained from DVT patients (n=42) and healthy controls (n=42). Gain- and loss-of-function studies of hsa_circRNA_092488 were carried out. The expression levels of related RNAs and proteins were examined by quantitative real-time reverse-transcription polymerase chain reaction, western blotting and immunofluorescence assays. The proliferation, migration, cell cycle progression, and apoptosis of transfected cells were measured by CCK-8 assay, transwell assay, and flow cytometry. The association of hsa_circRNA_092488 and NOD-like receptor protein 3 (NLRP3) in EPCs was revealed using RNA pull-down analysis. Furthermore, the stability of NLRP3 mRNA was examined in transfected EPCs.</p><p><strong>Results: </strong>Upregulation of hsa_circRNA_092488 was detected in blood samples from DVT patients and it had the ability to suppress the proliferation and migration of EPCs, induce cell cycle arrest from the S to the G0/G1 phase, and trigger cellular apoptosis. Furthermore, NLRP3 was identified as the potential downstream target molecule of hsa_circRNA_092488 and it could exert its regulatory functions by activating the NLRP3/nuclear factor (NF)-κB signaling pathway. Overexpression of hsa_circRNA_092488 in cells notably elevated the protein expression of caspase-1, interleukin-1β, P-NF-κB-p65/NF-κB-p65, and P-IκBα/IκBα, while knockdown of hsa_circRNA_092488 significantly reduced the levels of those proteins in EPCs.</p><p><strong>Conclusion: </strong>hsa_circRNA_092488/NLRP3/NF-κB signaling could be a novel therapeutic candidate for the treatment of DVT.</p>","PeriodicalId":23362,"journal":{"name":"Turkish Journal of Hematology","volume":" ","pages":"108-118"},"PeriodicalIF":1.5,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12099489/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143567683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Large and Multi-Nuclei Blasts in Acute Myeloid Leukemia with the Hypotriploid Karyotype and TP53 Mutation with P210 BCR::ABL1 Transcript 低三倍体核型和TP53突变急性髓系白血病伴P210 BCR::ABL1转录物的大核和多核细胞。
IF 1.5 4区 医学
Turkish Journal of Hematology Pub Date : 2025-05-22 Epub Date: 2025-04-21 DOI: 10.4274/tjh.galenos.2025.2025.0428
Yihong Huangchuan, Xueyan Chen
{"title":"Large and Multi-Nuclei Blasts in Acute Myeloid Leukemia with the Hypotriploid Karyotype and <i>TP53</i> Mutation with P210 <i>BCR::ABL1</i> Transcript","authors":"Yihong Huangchuan, Xueyan Chen","doi":"10.4274/tjh.galenos.2025.2025.0428","DOIUrl":"10.4274/tjh.galenos.2025.2025.0428","url":null,"abstract":"","PeriodicalId":23362,"journal":{"name":"Turkish Journal of Hematology","volume":" ","pages":"146-147"},"PeriodicalIF":1.5,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12099481/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143984207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信